Advertisement

Nocardiosis and Actinomycosis

  • Heather E. ClaussEmail author
  • Bennett Lorber
Chapter

Abstract

Nocardia species are strictly aerobic, gram-positive, branching, filamentous rods which are beaded appearing and stained variably with the modified acid-fast Kinyoun stain. They can fragment into pleomorphic, rod-shaped, or coccoid pieces. Nocardia are sometimes difficult to recognize and identify in the laboratory, leading to delays in clinical diagnosis. Their relatively slow growth can result in the cultures being discarded before the colonies can be seen. Nocardia are found most often in the environment in soil, water, and vegetation. More than half of the time, these organisms are opportunistic pathogens, causing disease in both solid organ and stem cell transplantations. Less recognized as opportunistic pathogens are Actinomyces species, gram-positive, anaerobic bacilli which are not acid-fast. These organisms are morphologically similar to Nocardia species and can be confused on Gram staining. Nocardia and Actinomycetes cause distinct syndromes which will be reviewed here.

Keywords

Nocardiosis Actinomycosis Organ transplantation Pneumonia Brain abscess 

References

  1. 1.
    Sorrell TC, Mitchell DH, Iredell JR, Chen SCA. Nocardia Species. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone; 2010. p. 3199–207.Google Scholar
  2. 2.
    Brown-Elliott BA, Brown JM, Conville PS, Wallace PJ Jr. Clinical and laboratory features of the Nocardia species based on current molecular taxonomy. Clin Microbiol Rev. 2006;19(2):259–82.CrossRefGoogle Scholar
  3. 3.
    Dorman SE, Guide SV, Conville PS, DeCarlo ES, Malech HL, Gallin JI, Witebsky FG, Holland SM. Nocardia infection in chronic granulomatous disease. Clin Infect Dis. 2002;35(4):390–4.CrossRefGoogle Scholar
  4. 4.
    Beaman L, Beaman BL. Monoclonal antibodies demonstrate that superoxide dismutase contributes to protection of Nocardia asteroides within the intact host. Infect Immun. 1990;58(9):3122–8.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev. 1994;7(2):213–64.CrossRefGoogle Scholar
  6. 6.
    Santos M, Gil-Brusola A, Morales P. Infection by Nocardia in solid organ transplantation: thirty years of experience. Transplant Proc. 2011;43(6):2141–4.CrossRefGoogle Scholar
  7. 7.
    Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, Shutt KA, Kwak EJ, Paterson DL. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis. 2007;44(10):1307–14.CrossRefGoogle Scholar
  8. 8.
    Peleg AY, Husain S, Kwak EJ, Silveira FP, Ndirangu M, Tran J, et al. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis. 2007;44(2):204–12.CrossRefGoogle Scholar
  9. 9.
    Kundranda MN, Spiro TP, Muslimani A, Gopalakrishna KV, Melaragno MJ, Daw HA. Cerebral nocardiosis in a patient with NHL treated with rituximab. Am J Hematol. 2001;82(11):1033–4.CrossRefGoogle Scholar
  10. 10.
    Corales R, Chua J, Mawhorter S, Young JB, Starling R, Tomford JW, et al. Significant post-transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon? Transpl Infect Dis. 2000;2(3):133–9.CrossRefGoogle Scholar
  11. 11.
    Doraiswamy VA. Nocardia infection with adalimumab in rheumatoid arthritis. J Rheumatol. 2008;35(3):542–3.PubMedGoogle Scholar
  12. 12.
    Lerner PI. Nocardiosis. Clin Infect Dis. 1996;22(6):891–903.CrossRefGoogle Scholar
  13. 13.
    Martínez TR, Menéndez VR, Reyes CS, Santos DM, Vallés Tarazona JM, Modesto AM, Gobernado SM. Pulmonary nocardiosis: risk factors and outcomes. Respirology. 2007;12(3):394–400.CrossRefGoogle Scholar
  14. 14.
    Torres HA, Reddy BT, Raad II, Tarrand J, Bodey GP, Hanna HA, Rolston KV, Kontoyiannis DP. Nocardiosis in cancer patients. Medicine. 2002;81(5):388–97.CrossRefGoogle Scholar
  15. 15.
    Chouciño C, Goodman SA, Greer JP, Stein RS, Wolff SN, Dummer JS. Nocardial infections in bone marrow transplant recipients. Clin Infect Dis. 2002;23(5):1012–9.CrossRefGoogle Scholar
  16. 16.
    Van Burik J, Hackman RC, Nadeem SQ, Hiemenz JW, White MH, Flowers ME, Bowden RA. Nocardiosis after bone marrow transplantation: a retrospective study. Clin Infect Dis. 1997;24(6):1154–60.CrossRefGoogle Scholar
  17. 17.
    Clark NM. Nocardia in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S70–7.CrossRefGoogle Scholar
  18. 18.
    Smego RA Jr, Moeller MB, Gallis HA. Trimethoprim-sulfamethoxazole for treatment of Nocardia infections. Arch Intern Med. 1983;143(4):711–8.CrossRefGoogle Scholar
  19. 19.
    Cercenado E, Marin M, Sanchez-Martinez M, Cuevas O, Martinez-Alarcon J, Bouza E. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother. 2007;51(3):1102–4.CrossRefGoogle Scholar
  20. 20.
    Garlando F, Bodmer T, Lee C, Zimmerli W, Pirovino M. Successful treatment of disseminated nocardiosis complicated by cerebral abscess with ceftriaxone and amikacin: case report. Clin Infect Dis. 1992;15(6):1039–40.CrossRefGoogle Scholar
  21. 21.
    Wren MV, Savage AM, Alford RH. Apparent cure of intracranial Nocardia asteroides infection by minocycline. Arch Intern Med. 1979;139(2):249–50.CrossRefGoogle Scholar
  22. 22.
    Moylett EH, Pacheco SE, Brown-Elliott BA, Perry TR, Buescher ES, Birhimngham MC, et al. Clinical experience with linezolid for the treatment of Nocardia infection. Clin Infect Dis. 2003;36(3):313–8.CrossRefGoogle Scholar
  23. 23.
    Mamelak AN, Obana WG, Flaherty JF, Rosenblum ML. Nocardial brain abscess: treatment and factors influencing outcome. Neurosurgery. 1994;35(4):622–31.CrossRefGoogle Scholar
  24. 24.
    Arduino RC, Johnson PC, Mirando AG. Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine. Clin Infect Dis. 1993;16(4):505–12.CrossRefGoogle Scholar
  25. 25.
    McNeil MM, Brown JM, Hutwagner LC, Schiff TA. Evaluation of therapy for Nocardia asteroides complex infections. Infect Dis Clin Pract. 1995;4:287–92.CrossRefGoogle Scholar
  26. 26.
    Blumel J, Blumel E, Yassin AF, Schmidt-Rotte H, Schaal KP. Typing of Nocardia farcinica by pulsed-field gel electrophoresis reveals an endemic strain as source of hospital infections. J Clin Microbiol. 1998;36(1):118–22.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Pulverer G, Schutt-Gerowitt H, Schaal KP. Human cervicofacial actinomycoses: microbiological data for 1997 cases. Clin Infect Dis. 2003;37(4):490–7.CrossRefGoogle Scholar
  28. 28.
    Russo TA. Agents of Actinomycosis. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone; 2010. p. 3209–19.Google Scholar
  29. 29.
    Sarkonen N, Kononen E, Summanen P, Kinervo A, Takala A, Jousimies-Somer H. Oral colonization with Actinomyces species in infants by two years of age. J Dent Res. 2000;79(3):864–7.CrossRefGoogle Scholar
  30. 30.
    Smego RA Jr, Foglia G. Actinomycosis. Clin Infect Dis. 1998;26(6):1255–61.CrossRefGoogle Scholar
  31. 31.
    Zitch RP 3rd, Bothwell M. Actinomycosis: a potential complication of head and neck surgery. Am J Otolaryngol. 1999;20(4):260–2.CrossRefGoogle Scholar
  32. 32.
    Chaudhry SI, Greenspan JS. Actinomycosis in HIV infection: a review of a rare complication. Int J STD AIDS. 2000;11(6):349–55.CrossRefGoogle Scholar
  33. 33.
    Cohen RD, Bowie WR, Enns R, Flint J, Fitzgerald JM. Pulmonary actinomycosis complicating infliximab therapy for Crohn’s disease. Thorax. 2007;62(11):1013–4.CrossRefGoogle Scholar
  34. 34.
    Gaffney R, Walsh M. Cervicofacial actinomycosis: an unusual cause of submandibular swelling. J Laryngol Otol. 1993;107(12):1169–70.CrossRefGoogle Scholar
  35. 35.
    Chen CY, Chen YC, Tang JL, Lin WC, Su IJ, Tien HF. Splenic actinomycotic abscess in a patient with acute myeloid leukemia. Ann Hematol. 2002;81(9):532–4.CrossRefGoogle Scholar
  36. 36.
    Leach TD, Sadek SA, Mason HC. An unusual abdominal mass in a renal transplant recipient. Transpl Infect Dis. 2002;4(4):218–22.CrossRefGoogle Scholar
  37. 37.
    Sims HS, Heywood BB. Post-transplant actinomycosis of the posterior glottis involving both vocal processes. Otolaryngology. 2007;137(6):967.CrossRefGoogle Scholar
  38. 38.
    Galaria II, Marcos A, Orloff M, Mieles L, Bozorgadeh KS, Tan HP. Pulmonary Actinomycosis in solid organ transplantation. Transplantation. 2003;75(11):1914.CrossRefGoogle Scholar
  39. 39.
    Bassiri AG, Girgis RE, Theodore J. Actinomyces odontolyticus thoracopulmonary infections: two cases in lung and heart-lung transplant recipients and a review of the literature. Chest. 1996;109(4):1109–11.CrossRefGoogle Scholar
  40. 40.
    Bennhoff D. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngocope. 1984;94(9):1198–217.CrossRefGoogle Scholar
  41. 41.
    Russo TA. Actinomycosis. In: Schlossberg D, editor. Clinical infectious disease. Hong Kong: Cambridge University Press; 2008. p. 881–5.CrossRefGoogle Scholar
  42. 42.
    Westhoff C. IUDs and colonization or infection with Actinomyces. Contraception. 2007;75(6 Suppl):S48–50.CrossRefGoogle Scholar
  43. 43.
    Hansen T, Kunkel M, Springer E, Walter C, Weber A, Siegel E, Kirkpatrick CJ. Actinomycosis of the jaws—histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch. 2007;451(6):1009–17.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Section of Infectious DiseasesLewis Katz School of Medicine at Temple UniversityPhiladelphiaUSA
  2. 2.Temple UniversityPhiladelphiaUSA
  3. 3.Temple University Hospital, Department of Infectious DiseasesPhiladelphiaUSA

Personalised recommendations